4-(tert-Butoxycarbonyl)-1-(5-chloropyrimidin-2-yl)piperazine-2-carboxylic acid

Catalog No. :
ACEXJY901
CAS No. :
1261229-66-6
Molecular Formula :
C14H19ClN4O4
Molecular Weight :
342.78

IUPAC Name:4-(tert-butoxycarbonyl)-1-(5-chloropyrimidin-2-yl)piperazine-2-carboxylic acid

4-(tert-Butoxycarbonyl)-1-(5-chloropyrimidin-2-yl)piperazine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$685.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(tert-Butoxycarbonyl)-1-(5-chloropyrimidin-2-yl)piperazine-2-carboxylic acid
IUPAC Name4-(tert-butoxycarbonyl)-1-(5-chloropyrimidin-2-yl)piperazine-2-carboxylic acid
MDL No.MFCD18380060
Molecular FormulaC14H19ClN4O4
Molecular Weight342.78
SMILESO=C(N1CC(C(O)=O)N(C2=NC=C(Cl)C=N2)CC1)OC(C)(C)C
InChI KeyOGEHQOJHDWSXAQ-UHFFFAOYSA-N
Synonym4-(5-Chloro-pyrimidin-2-yl)-piperazine-1,3-dicarboxylic acid 1-tert-butyl ester;1,3-Piperazinedicarboxylic acid, 4-(5-chloro-2-pyrimidinyl)-, 1-(1,1-dimethylethyl) ester
CAS No.1261229-66-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEXJY901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAURF768 route compound structure diagram
    ACAURF768128019-59-0 In Stock
  2. Plus
  3. ACDONH897 route compound structure diagram
    ACDONH89722536-67-0 In Stock
  4. Then
  5. ACEXJY901 route product structure diagram
    ACEXJY9011261229-66-6
Inquiry

2. ACEXJY901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEXJY901 route product structure diagram
    ACEXJY9011261229-66-6
Inquiry

Comments (0)